Evidence map›Paper›PMID 41369564›Full record

ArticleAntimicrobial agents and chemotherapy2026

The heme A synthase Cox15, as a target of redox-active 3-benzylmenadiones with antiparasitic activity.

Marcelo L Merli, Claudia Serot, Cindy Vallières, Julia A Cricco, Bogdan I Iorga, Elisabeth Davioud-Charvet, Brigitte Meunier

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marcelo L MerliInstituto de Biología Molecular y Celular de Rosario (IBR), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad Nacional de Rosario (UNR), Rosario, Santa Fe, Argentina.
Claudia SerotUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.
Cindy VallièresUniversité Paris-Saclay, CNRS UPR 2301, Institut de Chimie des Substances Naturelles (ICSN), Gif-sur-Yvette, France.
Julia A CriccoInstituto de Biología Molecular y Celular de Rosario (IBR), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad Nacional de Rosario (UNR), Rosario, Santa Fe, Argentina.
Bogdan I IorgaUniversité Paris-Saclay, CNRS UPR 2301, Institut de Chimie des Substances Naturelles (ICSN), Gif-sur-Yvette, France.ORCID 0000-0003-0392-1350
Elisabeth Davioud-CharvetUMR7042 CNRS-Unistra-UHA, Laboratoire d'Innovation Moléculaire et Applications (LIMA), European School of Chemistry, Polymers and Materials (ECPM), Strasbourg, France.ORCID 0000-0001-7026-4034
Brigitte MeunierUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.ORCID 0000-0002-6988-4663

Funding

Agence Nationale de la Recherche ANR-11-LABX-0024Agence Nationale de la Recherche ANR-22-CE93-0005-01Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT I A 2021-00274
6 · The paper itself

Abstract

Chagas disease, caused by

Indexed as

Antiparasitic AgentsSaccharomyces cerevisiae ProteinsTrypanocidal AgentsTrypanosoma cruziChagas DiseaseElectron Transport Complex IVHemeOxidation-ReductionSaccharomyces cerevisiaeAntiparasitic AgentsElectron Transport Complex IVHemeheme aSaccharomyces cerevisiae ProteinsTrypanocidal Agentsantiparasitic drugdrug mode of actionmitochondrial respiratory chainyeast model

Identifiers

PMID41369564
PMCPMC12777560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.